Little Free Libraries for Children
Little free libraries are beautiful, functional works of art that help build community. They develop literacy skills and encourage a love of reading by making it easy for families to exchange books in an informal, neighborhood setting.
Improve Parks with Shade Structures and Seating
Make parks and dog parks more comfortable for visitors by building one to two shelters with seating for rainy or sunny days. This project would also fund additional benches and tables in various parks across the city.
2016 Artists
Page detailing the artists who participated in the Community Supported Art program in Cambridge
Community Safety Department
The City of Cambridge is proposing a new Community Safety Department (CSD) that will coordinate community driven solutions to enhance safety in the community, with key services and programs targeted at our most vulnerable populations.
Share your ideas for improving Danehy Park
Danehy Park is a popular, 50-acre park in north Cambridge. For more than 30 years, residents and visitors have enjoyed the park’s athletic fields, walking paths, playgrounds, public art, dog park, and community events. We want Danehy Park to continue being a place that everyone can enjoy. We are starting a community process to gather ideas, information, and feedback about how to make Danehy even better!
CityView Newsletter
This publication is mailed to Cambridge residential households twice annually, generally in June and November. The summer issue highlights key City initiatives for the FY24 fiscal year from July 1, 2023 – June 30, 2024.
Home Essentials for Newly Housed Residents
Provide much needed supplies for previously unhoused Cambridge residents to set up their home in their new apartment. Upon leasing, these residents will receive a Home Furnishings Kit which will include bed, bath, and kitchen essentials.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.